Before the Event Intellectual Property Insurance
Your IP is likely to be the most valuable asset in your business and BTE IP insurance is the most cost effective way to mitigate significant risks to its value.
A number of our clients are early stage pharma companies looking to mitigate risk around their IP. Specifically the cost risk of being sued for infringing a third party’s rights or a third party infringing their rights. They are also looking to mitigate exposures under IP warranties and indemnities given to third parties.
Having BTE cover in place facilitates such licence agreements and also gives comfort to investors, lendors and licensees that, if a business critical event occurs, insurers will fund the litigation not them.
Below are some examples of the types of cover available. Premiums tend to range from around 0.5% to 1% of the amount of cover being sought per annum and is dependent on the development stage, therapeutic area and whether US cover is required.